Recent progress in antiretrovirals - lessons from resistance

Research output: Contribution to journalArticlepeer-review

34 Citations (Scopus)


Recent failures in efforts to develop an effective vaccine against HIV-1 infection have emphasized the importance of antiretroviral therapy in treating HIV-1-infected patients. Thus far, inhibitors of two viral enzymes, reverse transcriptase and protease, have had a profoundly positive impact on the survival of HIV-1-infected patients. However, new inhibitors that act at diverse steps in the viral replication cycle are urgently needed because of the development of resistance to currently available antiretrovirals. This review summarizes recent progress in antiretroviral drug discovery and development by specifically focusing on novel inhibitors of three phases of replication: viral entry, integration of the viral DNA into the host cell genome and virus particle maturation.
Original languageEnglish
Pages (from-to)424-432
JournalDrug Discovery Today
Issue number9-10
Publication statusPublished - May 2008


Dive into the research topics of 'Recent progress in antiretrovirals - lessons from resistance'. Together they form a unique fingerprint.

Cite this